The reason why the observational BC cardiotoxicity trial was scrapped appears to be that the degree of cardioprotection will be measured by varying the bisantrene dose.
Buy, Held
Ann: Race Strategic Update August 2023, page-10
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
-0.025(1.32%) |
Mkt cap ! $317.5M | |||
| Open | High | Low | Value | Volume |
| $1.97 | $2.02 | $1.85 | $1.189M | 605.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $1.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.89 | 30 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.86 |
Change
-0.025 ( 1.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.97 | $2.04 | $1.86 | 48029 | ||
| Last updated 15.57pm 13/06/2024 ? | |||||
| RAC (ASX) Chart |